Adaptive Biotechnologies to Present at the BofA Securities 2022 Healthcare Conference
May 02 2022 - 4:05PM
Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”)
(Nasdaq: ADPT), a commercial stage biotechnology company that aims
to translate the genetics of the adaptive immune system into
clinical products to diagnose and treat disease, today announced it
will be participating in the upcoming BofA Securities 2022
Healthcare Conference in Las Vegas, Nevada.
Adaptive Biotechnologies’ management is
scheduled to participate in a fireside chat Wednesday, May 11th at
8:40 a.m. Pacific Time / 11:40 a.m. Eastern Time. Interested
parties may access a live and archived webcast of the presentation
on the “Investors” section of the company website at:
www.adaptivebiotech.com.
About Adaptive Biotechnologies
Adaptive Biotechnologies is a commercial-stage
biotechnology company focused on harnessing the inherent biology of
the adaptive immune system to transform the diagnosis and treatment
of disease. We believe the adaptive immune system is nature’s most
finely tuned diagnostic and therapeutic for most diseases, but the
inability to decode it has prevented the medical community from
fully leveraging its capabilities. Our proprietary immune medicine
platform reveals and translates the massive genetics of the
adaptive immune system with scale, precision and speed to develop
products in our Immune Medicine and Minimal Residual Disease (MRD)
businesses. We have three commercial products and a robust clinical
pipeline to diagnose, monitor and enable the treatment of diseases
such as cancer, autoimmune conditions and infectious diseases. For
more information, please visit adaptivebiotech.com and
follow us on www.twitter.com/adaptivebiotech.
ADAPTIVE INVESTORSKarina Calzadilla, Vice
President, Investor Relations201-396-1687Carrie Mendivil, Gilmartin
Groupinvestors@adaptivebiotech.com
ADAPTIVE MEDIALaura Cooper, Senior Director,
Corporate
Communications206-693-2042lcooper@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Apr 2023 to Apr 2024